Chronix Biomedical Obtains $1,741,389 New Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=2b2ffa6e-c71a-430d-b3fc-612339000da0&Preview=1 - Date
9/15/2010 - Company Name
Chronix Biomedical - Mailing Address
1735 North First Street San Jose, CA 95112 - Company Description
Chronix Biomedical is pioneering a breakthrough approach to the diagnosis and management of chronic diseases and cancer. It has developed proprietary technology that measures and categorizes circulating nucleic acids, DNA sequences circulating in the blood that are associated with specific changes in disease and health status. The company plans to collaborate with a variety of partners to develop and market its DNA-based assays that have the potential to transform the management of a broad range of cancers and other conditions. Chronix is headquartered in San Jose, California and has research facilities in Germany. - Website
http://www.chronixbiomedical.com - Transaction Type
Venture Equity - Transaction Amount
$1,741,389 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. - M&A Terms
- Venture Investor
Undisclosed
